Medable platform reach

We’re on a mission to enable effective therapies to people faster.

A novel approach to research

For the past two decades clinical research has been hindered by outdated processes and technologies leaving millions without treatments.

After struggling to access patients in her own research in rare skin diseases, Dr. Michelle Longmire set out to solve this long-standing challenge in research.

Drawing inspiration from innovation and technological advancements in other industries, Longmire rallied stakeholders, partners, and developers to launch our company, Medable, with the shared vision of radically increasing the number of effective therapies to people each year.

Committed to science. Powered by innovation.

In order to achieve this vision, we needed to amplify the quality, reach, velocity, and cost of research.

Driven by the belief that clinical research can and should be better, we've assembled world-class scientific and product teams to continuously drive evidence-based improvements to the trial experience for all.

The relentless pursuit of progress, together.

Human connection is at the heart of everything we do. We prioritize the personal experience of patients, caregivers, knowing that their knowledge and feedback are essential to improving clinical research. In close partnership with with our network of sites, we continuously improve our platform, because we know that when they win, we all win. By designing products that are more accessible and user-friendly, we can bring life-change treatments to those who need them faster.

Together, with our clients and partners, we continue to work toward our mission and drive clinical research forward for the betterment of all.


The latest from Medable


Demo On Demand: eCOA+, patient & site experiences, and pulse oximeter sensor

6 min

VP of Solution Consulting, Jess Dolphi, showcases a few of the platform’s features, including site experience, patient experience, data and oversight dashboards, and a demonstration of connecting a pulse oximeter sensor for remote data capture.

White Papers, Case Studies, Reports

U.S. Renal Care achieves 75% site adoption of eConsent with Medable

Medable’s Total Consent, used by U.S. Renal Care in top ten pharma-sponsored study, proved to be a flexible, fast, and efficient solution for the elderly renal care population.


Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices

6 min

Industry experts from Medable and Harvard School of Medicine discuss how to equip your future digital/decentralized trial IRB & ethics submissions for success.

Prix Galien Best Digital Health Solution - Medable

Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution

6 min

Medable today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony. 

Tufts CSDD

New Research from Partnership for Advancing Clinical Trials (PACT) Reveals Decentralized Clinical Trials (DCTs) Beat Timeline Expectations

6 min

Medable today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in conjunction with the Tufts Center for the Study of Drug Development (CSDD) has produced compelling results from a new study.

Elderly Patients in US Renal Care Trial using Total Consent

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial

6 min

The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.

See how Medable can make your trials more efficient.